Medicalxpress.com (Feb. 26) — A cancer drug first tested in pet dogs begins human trials. “One of PAC-1’s greatest strengths is that it synergizes with other drugs, increasing the anti-cancer effects of many compounds that are out there,” said veterinary clinical medicine professor Timothy Fan.
Healthcanal (Feb. 26)
R&D Magazine (Feb. 27)
WCBU-89.9 FM (NPR; Peoria, Ill., March 30)
The Daily Illini (March 30)